Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @pharmaprodigy
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @pharmaprodigy
-
Kimberly Ha proslijedio/la je Tweet
Excited to announce
@endpts as a media partner for#BioFuture! Thanks for your support, excited to see everyone in April in NYC.
http://www.biofuture.com
#digitalhealth#pharma#biotech#healthcare#lifesciencespic.twitter.com/pQYYg7WKZ7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
This marks the first time a company is able to track
#SocialMedia activity for millions of HCPs around the world. The feature allows all global clients to track the social media activity of the HCP’s they care most about. Learn more here https://lnkd.in/gAPig9i#pharma#hcppic.twitter.com/M1GrFNHjYC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
Join Art Pappas, founder and managing partner at Pappas Capital at the
#BioFuture Conference, Apr 28-29 in NYC. Registration and company presentation requests are now open!
https://www.biofuture.com/registration/
#lifesciences#biotech#pharma#digitalhealthpic.twitter.com/fIJ5tsAykn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
Registration is now open for
#BioFuture! More details here:
https://www.biofuture.com/registration/
#biofuture#biotech#pharma#digitalhealthpic.twitter.com/l0ociCASOO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
These best line in $BIIB’s earnings PR: “This financial guidance does not include any impact from potential acquisitions or large business development transactions, as both are hard to predict.”
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
Met a pre-seed company whose CEO has an admin that is scheduling VC pitches - peak 2020.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
.
@ycombinator has accepted H1. into its latest cohort of companies in 2020. With Y Combinator's help, H1. wants to take its business global and develop applications for the pharmaceutical industry, care providers and ultimately consumers.
@TechCrunch for covering our story!pic.twitter.com/8M4HSQAtmV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
H1 Joins Y Combinator’s Winter 2020 Cohort and Expands Operations to San Francisco
@H1Insights#YCombinatorhttps://www.businesswire.com/news/home/20200128005435/en/H1-Joins-Combinator%E2%80%99s-Winter-2020-Cohort-Expands …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
H1 Insights is giving the healthcare industry the ultimate professional database https://tcrn.ch/36wXSGj by
@jshieberpic.twitter.com/2232F6Rpq4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
Building an accurate account of the professional ecosystem could be a huge help to businesses as diverse as pharmaceutical companies, hospitals, insurers, and, eventually, consumers - that's what H1. is doing!
#healthcare#healthtech#pharmahttps://twitter.com/TechCrunch/status/1221974605147099138 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
Welcome,
@mleslie45, to our Board! It's a privilege to have Mark's leadership and experience as we "build momentum in the cardiac MRI field and transform this sector of the healthcare industry."#AI#MRIhttps://www.businesswire.com/news/home/20200127005013/en/Mark-Leslie-VERITAS-CEO-Chairman-Joins-HeartVista …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
Gene editing biotech Beam Therapeutics sets terms for $100 million IPO
$BEAM$IPO#IPOhttp://zpr.io/tyYaMHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Happy Chinese New Year everyone!!
#CNY2020
#ChineseNewYear2020






pic.twitter.com/NhVcYENiSa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about? The
#biotech team covers all this and more on the latest episode of "The Readout LOUD"#podcast.https://buff.ly/37qF390Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
We are having a conference! One year from today. Educating people in all areas of Alzheimer’s. Nutrition, Medical, and Movement.https://twitter.com/4MOM_ALZ/status/1220429674049867776 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
It was a packed house this year, even on our last panel of the conference at
#DigitalShowcase: “How are investors placing their bets on digital medicine?”@luzhangvc@FusionFundVC@CareFirst@Rock_Health@MCK_Ventures@Launchpdh_SF@fredlaunchpdh@TEDRIDGWAY2#DeftaPartners
pic.twitter.com/Du8v1RqcPz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
Deerfield, one of the largest healthcare focused hedge funds, is betting BIG on both gene tx & the Philadelphia cluster. The venture will help with housing & relocation for experts who join, per release. They are calling it THE COLONY, a name JG Ballard would be proud of.https://twitter.com/syinvesting/status/1220439810915160066 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberly Ha proslijedio/la je Tweet
Goldman Sachs CEO David Solomon said over past 4 yrs performance of IPOs with a woman on the Board of Directors in US is significantly better than w/out a woman. "Starting on 7/1 in US & Europe we're not going to take a company public unless there's at least 1 diverse board 1/2
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks
@demycolton@EBDgroup for having me on the#IPO#CapitalMarkets panel at#BiotechShowcase#JPM20 with@UPMCEnterprises@JNJInnovation@MNakada@SVBLeerink@CovingtonLLP#biotech#pharma#fundingpic.twitter.com/Wv7G6dUjK8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
